Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance

Journal of Clinical Oncology

Volumn 23, Issue 3, 2005, Pages 448-454

  Mizutani, Yoichi ^a   Nakanishi, Hiroyuki ^a   Yamamoto, Kosuke ^a   Li, Yong Nan ^a   Matsubara, Hiroki ^a   Mikami, Kazuya ^a   Okihara, Koji ^a   Kawauchi, Akihiro ^a   Bonavida, Benjamin ^a   Miki, Tsuneharu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CARRIER PROTEIN; DIABLO PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CARRIER PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 20044376659     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.191     Document Type: Article

References (28)

1. Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma. N Engl J Med 335:865-875, 1996
2. Vaux DL, Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci U S A 93:2239-2244, 1996
3. Bratton SB, Walker G, Srinivasula SM, et al: Recruitment, activation and retention of caspase-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J 20:998-1009, 2001
4. van Gurp M, Festjens N, van Loo G, et al: Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304:487-497, 2003
5. Du C, Fang M, Li Y, et al: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42, 2000
6. Verhagen AM, Ekert PG, Pakusch M, et al: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53, 2000
7. Srinivasula SM, Datta P, Fan XJ, et al: Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 275:36152-36157, 2000
8. Fulda S, Wick W, Weller M, et al: Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8:808-815, 2002
9. Ng CP, Bonavida B: X-linked inhibitor of apoptosis (XIAP) blocks Apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: Sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pi (Smac/DIABLO). Mol Cancer Ther 1:1051-1058, 2002
10. Yoo NJ, Kim HS, Kim SY, et al: Immunohistochemical analysis of Smac/DIABLO expression in human carcinomas and sarcomas. APMIS 111:382-388, 2003
11. Fogh J: Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis and bladder tumors. Natl Cancer Inst Monogr 49:5-9, 1978
12. Mizutani Y, Bonavida B, Koishihara Y, et al: Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum (II) by anti-interleukin-6 monoclonal antibody or anti-interleukin-6-receptor monoclonal antibody. Cancer Res 55:590-596, 1995
13. Mizutani Y, Kamoi K, Ukimura O, et al: Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. J Urol 168: 2650-2654, 2002
14. Mizutani Y, Wada H, Yoshida O, et al: Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res 9:1453-1460, 2003
15. Mizutani Y, Wada H, Fukushima M, et al: Prognostic significance of orotate phosphoribosyltransferase activity in bladder cancer. Cancer 100:723-731, 2004
16. Yagoda A: Chemotherapy of renal cell carcinoma: 1983-1989. Semin Urol 7:199-206, 1989
17. Kolenko V, Uzzo RG, Bukowski R, et al: Dead or dying: Necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res 59:2838-2842, 1999
18. Gerhard MC, Zantl N, Weirich G, et al: Functional evaluation of the apoptosome in renal cell carcinoma. Br J Cancer 89:2147-2154, 2003
19. Bukowski RM: Natural history and therapy of metastatic renal cell carcinoma. CANCER 80: 1198-1220, 1997
20. Deveraux QL, Reed JC: IAP family proteins-suppressors of apoptosis. Genes Dev 13:239-252, 1999
21. Sasaki H, Sheng Y, Kotsuji F, et al: Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60:5659-5666, 2000
22. Goyal L: Cell death inhibition: Keeping caspases in check. Cell 104:805-808, 2001
23. Srinivasula SM, Hegde R, Saleh A, et al: A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116, 2001
24. Arnt CR, Chiorean MV, Heldebrant MP, et al: Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ. J Biol Chem 277: 44236-44243, 2002
25. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 281:1305-1308, 1998
26. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med 5:157-163, 1999
27. Mizutani Y, Yoshida O, Miki T, et al: Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. Clin Cancer Res 5:2605-2612, 1999
28. Mizutani Y, Nakanishi H, Yoshida O, et al: Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. Eur J Cancer 38:167-176, 2002